SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Pharmaceutical giant Allergan Plc is backing out of its deal with San Diego-based Adamis Pharmceuticals Corp. to commercialize the firm’s epinephrine pre-filled syringe for the treatment of life-threatening allergic reactions (anaphylaxis).
Local digital health company AristaMD raised $11 million in a Series A financing, the company announced Friday.
The University of California, San Diego is opening an office in downtown Tokyo, where researchers will seek partnerships with Japan’s booming life science industry.
San Diego’s SpectraScience Inc., a medical device company using light technologies to detect and diagnose cancers, has signed a distribution agreement with Advanced Medical German Co. (AMG) in Kuwait to be its exclusive distributor in the Middle East.
Carlsbad drugmaker Ionis Pharmaceuticals Inc. has earned $10 million from Janssen Biotech Inc. by licensing out its gastrointestinal (GI) drug candidate, IONIS-JBI1-2.5Rx.
Gene sequencing giant Illumina Inc. is calling for startups to apply to its business accelerator program for early-stage businesses in the genomics space.
San Diego molecular information firm AltheaDx Inc. has raised $2.2 million in debt financing, according to a form recently filed with the Securities and Exchange Commission.
Leaders in San Diego’s genomics industry will address challenges and ideas in the precision medicine space at a local conference in August.
Arena Pharmaceuticals’ weight-loss drug, Belviq, has been approved for commercialization in Mexico, gaining Arena a milestone payment of $1 million.
BIOTECH: NuVasive’s Lucier Sets Cadence for Co.’s March Toward Its Goals
Greg Lucier ranks high on my list of San Diego bigwigs, but the biotech executive has largely eluded me for the past two years.
San Diego’s Abreos Biosciences has raised $725,000 in a seed round of funding.
San Diego’s Oncternal Therapeutics Inc. has been granted an Orphan Drug Designation by the U.S. Food and Drug Administration for its pediatric cancer drug candidate.
BioSurplus Inc., a local company that buys and sells pre-owned lab equipment, has appointed Bill VanDeWeghe as its new president and chief executive officer.
CASIS, the organization that manages the U.S. national lab on the International Space Station, is setting up a permanent office in San Diego, Mayor Keven Faulconer announced on July 12.